Google Chrome
Safari
Firefox
Edge
Search
Analytical Characterization
Hovione advanced characterization capabilities of inhalation and nasal products is crucial to determine their safety and efficacy.
Press Release / May 03, 2023
Hovione and H&T Presspart extend partnership to advance high efficiency device technology for Dry Powder Inhalation formulation delivery
Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart have entered in a strategic partnership to advance the development of Presspart's Sunriser© Capsule-based Dry Powder Inhaler platform.
Article / Apr 30, 2010
Inhalation: Going Beyond Asthma. Interview: Peter Villax and Jason Suggett
Drug Delivery Technology, April 2010
Particle Engineering for Inhalation and Nasal
Hovione is a global expert and recognized leader in particle engineering, an essential technology when developing inhalation drug products.
Filling
Fully-integrated Filling for your device needs.
Article / Feb 01, 2014
Particle Engineering for Inhaled Therapeutics
Pharmaceutical Technology Europe, February 2014
Press Release / Nov 29, 2023
Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Sunriser® DPI
High Performance, High-Dose Capsule DPI.